Growing evidence has demonstrated that NRP-1 was frequently overexpressed and associated with poor prognosis in gastric cancer, melanoma, bladder cancer, cervical cancer, hepatocellular carcinoma, as well as breast cancer [28-33]. This evidence concerns the gene NRP1 and hepatocellular carcinoma.